|
Market Cap (24-Jun) $7,649,007 (1,598th) |
Close (30-Jun) $0.024 |
Volume (30-Jun) 2,170,184 |
Shortsold (2-Feb) 3,141 (0.00%) (662nd) |
|
52w High $0.008 |
52w Low $0.002 |
P/E - |
EPS 0 |
1AD released this announcement to the ASX on 24 January 2023, 9:06. The announcement is not marked as price sensitive, and is 2 page(s) in length and 234.04kb in size.
You can view all announcements from 1AD and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from 1AD | |
|---|---|
| AD-214 clinical trial approval | 29 June 2023, 8:21 |
| Change in substantial holding | 31 May 2023, 13:30 |
| Change in substantial holding | 31 May 2023, 9:34 |
| Ceasing to be a substantial holder | 24 January 2023, 9:06 |
| Second Japan patent for AD-214 | 10 January 2023, 8:20 |
| Results of Meeting | 22 November 2022, 12:38 |
| Chair address and CEO presentation to AGM | 22 November 2022, 9:12 |
You must be logged in to post a reply.
AdAlta 